Pharmagest reported unaudited sales results for the third quarter and nine months ended September 30, 2013. For the quarter, the company reported sales of €25.45 million compared to €24.57 million a year ago period.

For the nine months, the company reported sales of €84.59 million compared to €79.60 million a year ago period.

For the end of the year, the Group forecasts sustained growth at a rate identical to that of the last two quarters of Fiscal Year 2013.